To include your compound in the COVID-19 Resource Center, submit it here.

Diovan valsartan: Phase IV data; Marketed to treat hypertension

In NOVN's 2-year international Val-HeFT trial of 5,010 heart failure patients receiving other therapies, Diovan reduced the

Read the full 174 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE